Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.
Paying user area
Try for free
Eli Lilly & Co. pages available for free this week:
- Balance Sheet: Assets
- Analysis of Liquidity Ratios
- Enterprise Value (EV)
- Dividend Discount Model (DDM)
- Present Value of Free Cash Flow to Equity (FCFE)
- Selected Financial Data since 2005
- Return on Equity (ROE) since 2005
- Total Asset Turnover since 2005
- Price to Book Value (P/BV) since 2005
- Price to Sales (P/S) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Eli Lilly & Co. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Eli Lilly & Co., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
US$ in thousands
Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Short-term borrowings and current maturities of long-term debt
- This liability exhibits notable volatility with sharp decreases and increases across quarters. The balance falls significantly from March 2020 to December 2020, rises moderately during 2021, and then spikes sharply at the end of 2023, reaching particularly high levels in late 2024 and into 2025, suggesting fluctuating short-term debt refinancing or liquidity management strategies.
- Accounts payable
- Accounts payable generally display an upward trend over the periods, increasing from around 1.2 billion in early 2020 to over 4 billion by mid-2025, indicating possibly increased purchasing activities or extended payment terms.
- Employee compensation
- Employee compensation shows a pattern of partial recovery after decreases in early 2021 but with considerable fluctuations. The amounts increase dramatically in late 2023 and throughout 2024, peaking in December 2024, possibly reflecting variable workforce costs or incentive payments.
- Sales rebates and discounts
- Sales rebates and discounts steadily increase from about 4.7 billion in early 2020 to over 14.5 billion by early 2025. This upward trend suggests growing sales volume or increased discounting practices, impacting gross revenue recognition.
- Dividends payable
- Dividends payable demonstrate an intermittent presence beginning in late 2020, generally increasing through the years with new highs approaching 1.35 billion by early 2025. This indicates growing dividend obligations, consistent with a potential strategy of returning value to shareholders.
- Short-term income taxes payable
- This liability appears only in the last quarters of the dataset and shows a sharp rise from approximately 1.1 billion to nearly 7 billion by mid-2025, which may reflect evolving tax liabilities or changes in tax payment timing.
- Other current liabilities
- Other current liabilities are volatile, peaking around late 2020, decreasing in mid-2022, then increasing again by the end of 2024 and into 2025, reaching values above 5 billion. The variability suggests fluctuations in accrued expenses or miscellaneous current liabilities.
- Current liabilities
- The total current liabilities fluctuate substantially, with notable increases toward the end of 2023 and continuing growth through 2024 and 2025, ultimately surpassing 39 billion. This indicates an overall increase in short-term financial obligations.
- Long-term debt, excluding current maturities
- Long-term debt remains relatively stable between 13.9 billion and 18.3 billion through 2020 to 2021 but then rises notably in 2023 and significantly spikes in 2024 and 2025, reaching above 34 billion, which reflects a considerable increase in long-term borrowing or refinancing activities.
- Accrued retirement benefits
- Accrued retirement benefits display a declining trend over the observed periods, decreasing from over 3.6 billion in early 2020 to around 1.3 billion by the end of 2024, indicating potential settlement of liabilities or changes in actuarial assumptions.
- Long-term income taxes payable
- Long-term income taxes payable remain within a range of approximately 3.3 to 4.4 billion through most periods, with a noticeable increase toward mid-2025 to above 5.6 billion, showing rising deferred tax liabilities or tax planning adjustments.
- Other noncurrent liabilities
- Other noncurrent liabilities steadily decline from about 4 billion in early 2020 to approximately 1.8 billion by late 2022, then slightly rebound to around 2.3 billion in 2024 and 2025, indicating a reduction in less-liquid obligations followed by stabilization.
- Noncurrent liabilities
- Noncurrent liabilities fluctuate between roughly 25 billion and 28 billion until mid-2021, decline somewhat in 2022, then increase sharply from 2023 onward, surpassing 43 billion by mid-2025. This trend suggests a significant accumulation in long-term obligations.
- Total liabilities
- Total liabilities maintain a level around 37 to 40 billion through 2020 to 2021, with steady growth noted starting 2022 and accelerating through 2024 and 2025, culminating in approximately 82.6 billion by mid-2025. This reflects an overall expansion of the company’s debt and payable balances.
- Common stock
- The common stock value remains relatively constant near 600 million throughout the periods, indicating no major issuances or repurchases affecting par value.
- Additional paid-in capital
- Additional paid-in capital fluctuates mildly but generally shows a slight upward trend from 6.5 billion to near 7.1 billion by mid-2025, reflecting occasional equity transactions or adjustments.
- Retained earnings
- Retained earnings generally increase from approximately 5.9 billion in early 2020 to over 17.3 billion by mid-2025, indicating a consistent accumulation of profits or earnings retained within the company despite some quarter-to-quarter variability.
- Employee benefit trust
- The employee benefit trust balance remains constant at negative 3 billion across all periods, signaling unchanged holdings or reserved amounts related to employee benefits.
- Accumulated other comprehensive loss
- Accumulated other comprehensive loss narrows from about negative 6.9 billion in early 2020 to around negative 3.7 billion by mid-2022 but then widens again to near negative 4.3 billion by late 2024 before improving slightly by mid-2025, showing fluctuations in unrealized gains and losses.
- Cost of common stock in treasury
- The cost related to common stock in treasury generally decreases from about negative 55.7 million to near negative 32.7 million by 2024, with fluctuations thereafter, indicating possibly some buyback activity or adjustments in treasury stock values.
- Total shareholders’ equity
- Equity attributable to the company increases overall from approximately 3.1 billion in early 2020 to over 18.2 billion by mid-2025, with gradual growth concentrated during 2023 and 2024, suggesting strong capitalization and profitability retention.
- Noncontrolling interests
- Noncontrolling interests stay relatively small and stable, fluctuating between 75 million and 219 million through the timeline, with minor declines after mid-2021.
- Total equity
- Total equity follows a similar upward trajectory as the company shareholders’ equity, moving from about 3.2 billion to over 18.3 billion, mirroring improvements in company financial strength.
- Total liabilities and equity
- The aggregate amount of liabilities and equity rises steadily from around 41.1 billion in early 2020 to over 100.9 billion by mid-2025, reflecting organizational growth and expanded financing over the interval.